SCIENTIFIC EXPERTISE IN ONCOLOGY AND BONE DISEASES
Over 20 years of experience in leading biomedical research and business.
September 18, 2023 | OncoBone article

September 18, 2023

OncoBone is now a Virtual CRO

In November 2022 OncoBone Ltd received grant funding from ELY Centre of Finland and European Union for developing a Virtual CRO concept as a new business model. OncoBone has now completed the work and is officially a Virtual CRO.

Jussi Halleen, CEO of OncoBone Ltd says: “I am proud to state that OncoBone is now officially a Virtual CRO. I want to thank ELY Centre of Finland and European Union for the grant support, which was extremely important for OncoBone to complete the project.”

OncoBone representatives have a long history of working in CRO business and a large global network of high-quality CRO partners. When you contract OncoBone as your Virtual CRO, OncoBone will subcontract all laboratory work to mutually selected expert CROs, manage the subcontracted work as your Study Monitor, and take full responsibility for the subcontracted work for you.

You can read more details about the Virtual CRO concept in our new webpages at https://oncobone.com/virtual-cro.

OncoBone

AT YOUR SERVICE

If you are interested to learn more,
see our services or contact us directly.

    Scientist.com logo Science Exchange logo

    Copyright © 2024 OncoBone Ltd